作者: Shuncong Wang , Jianjun Tang , Tiantian Sun , Xiaobin Zheng , Jie Li
DOI: 10.1038/S41598-017-01571-0
关键词:
摘要: Small cell lung cancer (SCLC), as a proportion, makes up only 15–17% of cases. The development treatments for SCLC has remained stagnant decades, and is expected to persist threat human health. To date, no publications based on large populations have been reported. We calculated survival changes in patients with during each decade between 1983 2012 determine the roles race, sex, age, socioeconomic status (SES) rates Surveillance, Epidemiology, End Results (SEER) registries. In total, 106,296 were identified, overall incidence per 100,000 decreasing from 9.6 7.8 5.8. median 7 months, 12-month relative (RSRs) relatively stable at 32.9%, 33.2% decade. 5-year RSRs significantly improved 4.9% 5.9% 6.4% decade, but extremely low. addition, narrowing gaps among SES groups sexes observed. Although decreased stable, highlighting urgency developing novel importance prevention early detection.